HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akinobu Taketomi Selected Research

amatuximab

10/2021Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model.
2/2021Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
9/2018The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akinobu Taketomi Research Topics

Disease

130Neoplasms (Cancer)
08/2022 - 12/2004
97Hepatocellular Carcinoma (Hepatoma)
10/2022 - 08/2004
40Neoplasm Metastasis (Metastasis)
08/2022 - 10/2005
18Liver Cirrhosis (Hepatic Cirrhosis)
07/2021 - 01/2008
18Fibrosis (Cirrhosis)
07/2021 - 11/2006
18Cholangiocarcinoma
01/2021 - 01/2006
17Liver Diseases (Liver Disease)
10/2019 - 04/2007
14Infections
01/2022 - 07/2007
13Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 09/2015
13Pathologic Constriction (Stenosis)
01/2022 - 06/2006
12Rectal Neoplasms (Rectal Cancer)
08/2022 - 01/2008
12Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 04/2007
12Lymphatic Metastasis
06/2020 - 03/2008
11Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
02/2014 - 01/2008
10Colonic Neoplasms (Colon Cancer)
08/2022 - 01/2008
10Stomach Neoplasms (Stomach Cancer)
04/2022 - 09/2014
10Non-alcoholic Fatty Liver Disease
07/2021 - 11/2008
10Carcinoma (Carcinomatosis)
07/2018 - 01/2006
10Hepatitis C
11/2017 - 12/2004
9Adenocarcinoma
05/2021 - 05/2010
8Carcinogenesis
08/2022 - 02/2009
8Liver Neoplasms (Liver Cancer)
04/2022 - 05/2007
8Inflammation (Inflammations)
01/2022 - 05/2006
8Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 12/2004
8Hepatitis B
06/2019 - 08/2004
6Hemorrhage
04/2018 - 05/2006
6End Stage Liver Disease
02/2015 - 09/2009
5Pain (Aches)
08/2022 - 12/2014
5Ischemia
07/2020 - 07/2015
5Reperfusion Injury
07/2020 - 07/2015
4Sepsis (Septicemia)
08/2022 - 01/2008
4Hepatoblastoma
01/2022 - 11/2013
4Liver Failure
08/2020 - 09/2007
4Wounds and Injuries (Trauma)
09/2017 - 07/2009
4Chronic Hepatitis C
02/2015 - 01/2009
4Hepatitis
08/2014 - 07/2007
4Ascites
06/2012 - 01/2008
3Pneumoperitoneum
01/2022 - 08/2018
3Peritonitis
01/2022 - 01/2018
3Melanoma (Melanoma, Malignant)
10/2021 - 08/2017

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2010
14Proteins (Proteins, Gene)FDA Link
04/2020 - 07/2007
13InterferonsIBA
08/2022 - 01/2009
10Biological ProductsIBA
01/2021 - 05/2007
9alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2022 - 01/2005
9acarboxyprothrombin (PIVKA)IBA
06/2020 - 12/2004
8CytokinesIBA
04/2022 - 03/2008
8GemcitabineFDA Link
10/2021 - 01/2006
8MesothelinIBA
10/2021 - 12/2012
7Indicators and Reagents (Reagents)IBA
04/2020 - 07/2007
6Capsules (Microcapsules)IBA
08/2017 - 11/2008
6Ribavirin (Virazole)FDA LinkGeneric
08/2017 - 05/2010
5Immunoglobulins (Immunoglobulin)IBA
04/2022 - 09/2007
5Antiviral Agents (Antivirals)IBA
01/2021 - 07/2008
5AlbuminsIBA
06/2020 - 05/2011
5MucinsIBA
01/2020 - 05/2007
5Fetal Proteins (Fetoprotein)IBA
06/2019 - 06/2011
5BilirubinIBA
01/2019 - 01/2008
5Alanine Transaminase (SGPT)IBA
11/2015 - 01/2008
4Vitamin KFDA Link
01/2022 - 06/2012
4Immunosuppressive Agents (Immunosuppressants)IBA
12/2020 - 04/2007
4Cisplatin (Platino)FDA LinkGeneric
05/2020 - 01/2006
4Pharmaceutical PreparationsIBA
03/2020 - 12/2010
4Interleukin-6 (Interleukin 6)IBA
12/2019 - 02/2016
4EnzymesIBA
11/2019 - 11/2008
4Contrast MediaIBA
01/2019 - 01/2006
4Tumor Biomarkers (Tumor Markers)IBA
04/2018 - 05/2008
4Fatty Acids (Saturated Fatty Acids)IBA
03/2018 - 11/2008
4ferric oxide (iron oxide)IBA
09/2012 - 10/2005
4Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2011 - 11/2007
3lenvatinibIBA
08/2022 - 02/2020
3Diacylglycerol KinaseIBA
04/2022 - 07/2012
3LigandsIBA
04/2022 - 10/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2011
3Immune Checkpoint InhibitorsIBA
10/2021 - 08/2020
3amatuximabIBA
10/2021 - 09/2018

Therapy/Procedure

81Liver Transplantation
08/2022 - 12/2004
47Hepatectomy
07/2022 - 01/2007
41Therapeutics
08/2022 - 02/2006
17Drug Therapy (Chemotherapy)
08/2022 - 01/2006
10Transplantation
08/2022 - 12/2004
8Gastrectomy
04/2022 - 09/2014
7Neoadjuvant Therapy
03/2022 - 04/2013
7Immunotherapy
10/2017 - 07/2010
7Splenectomy
08/2014 - 02/2009
5Pancreaticoduodenectomy
07/2022 - 04/2007
5Laparotomy
01/2022 - 05/2009
5Lymph Node Excision (Lymph Node Dissection)
01/2022 - 05/2008
5Adjuvant Chemotherapy
10/2021 - 07/2008
5Catheters
06/2021 - 12/2014
5Proctectomy
01/2021 - 01/2008
4Operative Time
01/2019 - 09/2012
4Length of Stay
01/2019 - 11/2015
4Colectomy
07/2018 - 06/2016
4Sutures (Suture)
05/2018 - 07/2012
4Radiofrequency Ablation
01/2018 - 07/2009
4Ligation
06/2013 - 03/2008
3Radiotherapy
07/2022 - 04/2013
3Chemoradiotherapy
01/2022 - 08/2018
3Operative Surgical Procedures
01/2022 - 10/2015